PRRT4, a member of the proline-rich transmembrane protein family, exhibits a unique yet not fully understood role in cellular processes. While its precise functions remain elusive, the predicted involvement in microtubule binding and microtubule motor activity suggests a potential role in intracellular transport and organization. Furthermore, its participation in processes such as establishment of cell polarity, positive regulation of cell-cell adhesion, and ureteric bud invasion implies a broader influence on cellular structure and interactions.
The activation of PRRT4 appears to be orchestrated through indirect modulation by various chemical agents targeting key cellular pathways. These pathways, intricately connected and responsive to environmental cues, ultimately converge on PRRT4, influencing its expression and function. Notably, calcium signaling emerges as a central theme, with activators impacting cellular calcium dynamics either by directly affecting channels or indirectly by modulating intracellular stores. Additionally, the inhibition of kinases such as PI3K, Src, p38 MAPK, and mTOR suggests the involvement of these signaling cascades in PRRT4 regulation. These findings underscore the complexity of PRRT4 activation, indicating its integration into diverse cellular signaling networks. In conclusion, while the exact role of PRRT4 in cellular processes remains a subject of ongoing exploration, the identified activators provide valuable insights into the intricate mechanisms influencing its expression and function. The convergence of diverse signaling pathways on PRRT4 highlights its position as a nodal point in cellular regulation, emphasizing the need for further investigation to unravel the intricacies of its biological functions and the interconnected signaling networks that govern its activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Indirectly activates PRRT4 by elevating intracellular calcium levels. A23187 induces calcium influx, triggering signaling pathways that influence PRRT4 expression and cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Activates PRRT4 through inhibition of PI3K. Wortmannin blocks PI3K activity, impacting downstream signaling cascades and indirectly modulating PRRT4 function and expression. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Indirectly activates PRRT4 by affecting calcium homeostasis. Dantrolene inhibits calcium release from the sarcoplasmic reticulum, influencing pathways that regulate PRRT4 expression and activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Activates PRRT4 through Src kinase inhibition. PP2 blocks Src kinase activity, leading to altered downstream signaling and influencing PRRT4 expression and cellular responses. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Indirectly activates PRRT4 by modulating calcium channels. Bay K8644 enhances calcium channel activity, influencing cellular calcium levels and pathways related to PRRT4 function and expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Activates PRRT4 indirectly through p38 MAPK inhibition. SB203580 inhibits p38 MAPK, impacting downstream signaling and influencing PRRT4 expression and cellular responses. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Indirectly activates PRRT4 by affecting mitochondrial calcium uptake. Ruthenium Red inhibits mitochondrial calcium transport, influencing pathways that modulate PRRT4 expression and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Activates PRRT4 through PI3K inhibition. LY294002 inhibits PI3K, disrupting downstream signaling cascades and indirectly modulating PRRT4 expression and cellular responses. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Indirectly activates PRRT4 by affecting endoplasmic reticulum calcium stores. Thapsigargin depletes ER calcium, triggering cellular responses that influence PRRT4 expression and function. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
Activates PRRT4 through mTOR inhibition. PP242 inhibits mTOR, impacting downstream signaling cascades and indirectly modulating PRRT4 expression and cellular responses. | ||||||